目前国内多数医院对于急性心肌梗塞 (发病 8小时以内的 )普遍采用尿激酶与阿斯匹林及肝素合用溶栓疗法 ,虽使冠脉再通率显著提高 ,但时有出血并发症的发生 ,而我们采用尿激酶加前列腺素Ｅ1 对其进行溶栓治疗与文献中单用尿激酶溶栓治疗结果的对比与尿激酶加阿斯匹林及肝素联合? At present, most hospitals in China for acute myocardial infarction (within 8 hours of onset) commonly used urokinase combined with aspirin and heparin thrombolytic therapy, although the coronary recanalization rate increased significantly, but sometimes the occurrence of bleeding complications, And we use urokinase plus prostaglandin E1 thrombolytic therapy with its single urokinase thrombolysis in the literature compared with urokinase plus aspirin and heparin?